| |
|
|
| |
Autologous Tissue Repair
Products, Players, and Prospects
|
Publication: Dec 2009
Product Code: ATR832B
|
The ability to isolate, purify and re-inject patient-derived
cells with regenerative properties has led to a number of
therapeutic products for the treatment of refractory
injuries and wounds. Autologous tissue repair is having an
impact on a number of areas, including cardiovascular
medicine, refractory wound care, orthopedics, and surgical
medicine. The potential economic benefits of autologous
tissue repair are significant, as an aging population
struggles with intractable ailments that historically have
required numerous follow-up provider visits. While several
autologous therapies require remote processing, the number
of therapeutic autologous products that can be processed at
the point-of-care is increasing. This report details the
autologous tissue repair products and development programs
of twenty-seven separate companies in seven countries -
companies working to shape the future of tissue
regeneration. |
|
Highlights |
· Analyzes and evaluates
autologous tissue repair products and product candidates
and assesses the market potential for existing and
probable future products
· Examines tissue repair
demand drivers and evolving market factors
· Forecasts the impact of
tissue regeneration technology and therapeutics on
application segments and projects probable future
developments
· Profiles autologous
tissue repair market participants, their technology,
product development activity, and business strategies
· Provides forecasts and
market data to 2012
|
|
Summary of Contents |
Executive Summary
Autologous Tissue
Repair – Market Structure
Tissue Repair Market
Segments
Demographics and Growth
Competitive
Landscape
Demand Drivers
Risk Factors
Therapeutic Application Segment Analysis
CNS
Orthopedic
Bone Graft Fixation
Ligament Repair
Surgical
Cardiovascular Procedures
Neurosurgical Procedures
Plastic/Cosmetic Surgery
Wound Care
Acute Trauma
Burns
Diabetic
Ulcers
Pressure Ulcers
Venous Ulcers
Autologous Therapeutics - Product Analysis, Outlook
and Forecasts
Chondrocyte Harvesting
Cardiovascular Grafts
Epidermal Grafts
Macrophage Activation
Skin Cell Suspension
Thrombin/Platelet Gels
Platelet Rich Plasma
Stem Cell Isolation
Market Factors
Clinical Trial Enrollment
FDA Guidelines
Reimbursement
Evolving Patient Demographics
Point-of-Care Processing
Protocols and End-Points
Autologous Tissue Repair Company Profiles
|
|
|
|
|
